LD-transpeptidase A | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

327,333 results for “LD-transpeptidase A”

IIT Roorkee Researchers Uncover Novel Mechanism of Antibiotic Resistance in E. coli

Ceftriaxone Shows Promise in Alleviating Fatigue in Post-Lyme Disease Syndrome

Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for Alvelestat in AATD-LD

Coya Therapeutics Advances Phase 1 Study of LD IL-2 + CTLA4-Ig in Frontotemporal Dementia

Multidimensional Inflammatory-Nutritional Risk Score Improves Post-Transplant Prognostication in HCC

ND0612 Shows Sustained Efficacy in Parkinson's Disease Motor Fluctuations

FDA Approves Crexont for Parkinson's Disease Treatment

CREXONT Shows Superior Efficacy in Phase 4 Trial, Delivering Over 3 Additional Hours of Daily "Good On" Time for Parkinson's Patients

FDA Approves AbbVie's Vyalev for Advanced Parkinson's Disease

Coya Therapeutics Publishes Preclinical Data Showing Complementary Immunomodulatory Effects of COYA 303 in Neuroinflammation Model

Page 1 of 4075